Browse result page of B3Pdb

The total number entries retrieved from this search are 76, scroll left/right for detailed information.
B3pdbIDPEPTIDE NAMEPEPTIDE SEQUENCE (1-letter)PEPTIDE SEQUENCE (3-letter)N-TERMINAL MODIFICATIONC-TERMINAL MODIFICATION CHEMICAL MODIFICATIONPEPTIDE LENGTHPEPTIDE CONFORMATIONPEPTIDE NATURESOURCE/ORIGIN OF PEPTIDESMILESCELL LINEIn vitro CONCENTRATIONIn vitro METHODIn vitro RESULTANIMAL MODELIn vivo CONCENTRATIONIn vivo MODE OF DELIVERYIn vivo METHODIn vivo RESULTACTIONTRANSPORT TYPESUBCELLULAR LOCALISATIONCOMBINATIONPHYSICAL CONDITIONRESPONSERESULTLABELPMID
b3pdb_0991TP10-2AGYLLGKINLKPLAALAKKIL-NH2Ala-Gly-Tyr-Leu-Leu-Gly-Lys-Ile-Asn-Leu-Lys-Pro-Leu-Ala-Ala-Leu-Ala-Lys-Lys-Ile-Leu-NH2NANANA21LinearNAChemically synthesizedNANANACapillary depletionNANANANANANA NA NA NA NA NA % capillary 14.71% Direct iodination 26465925
b3pdb_0992TP10-2AGYLLGKINLKPLAALAKKIL-NH2Ala-Gly-Tyr-Leu-Leu-Gly-Lys-Ile-Asn-Leu-Lys-Pro-Leu-Ala-Ala-Leu-Ala-Lys-Lys-Ile-Leu-NH2NANANA21LinearNAChemically synthesizedNANANACapillary depletionNANANANANANA NA NA NA NA NA % parenchyma 84.29% Direct iodination 26465925
b3pdb_0993TP10-2AGYLLGKINLKPLAALAKKIL-NH2Ala-Gly-Tyr-Leu-Leu-Gly-Lys-Ile-Asn-Leu-Lys-Pro-Leu-Ala-Ala-Leu-Ala-Lys-Lys-Ile-Leu-NH2NANANA21LinearNAChemically synthesizedNANANANANANANAIntravenous NANA NA Permeability NA NA NA Unidirectional influx rate constant 0.000359 mL/(g x min) Direct iodination 26465925
b3pdb_0994TP10-2AGYLLGKINLKPLAALAKKIL-NH2Ala-Gly-Tyr-Leu-Leu-Gly-Lys-Ile-Asn-Leu-Lys-Pro-Leu-Ala-Ala-Leu-Ala-Lys-Lys-Ile-Leu-NH2NANANA21LinearNAChemically synthesizedNANANANANANANAIntravenous NANA NA Permeability NA NA NA Initial disrobution volume 0.01007 ml/g Direct iodination 26465925
b3pdb_1088Ziconotide, SNX-111,CKGKGAKCSRLMYDCCTGSCRSGKCCys-Lys-Gly-Lys-Gly-Ala-Lys-Cys-Ser-Arg-Leu-Met-Tyr-Asp-Cys-Cys-Thr-Gly-Ser-Cys-Arg-Ser-Gly-Lys-CysNANACys1-Cys16; Cys8-Cys20; Cys15-Cys2525LinearNAChemically synthesizedC[C@H]1C(=O)N[C@H](C(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N1)CCCCN)CCCCN)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N3)CO)[C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)CO)CCCNC(=N)N)CC(C)C)CCSC)CC4=CC=C(C=C4)O)CC(=O)O)C(=O)N)CCCCN)CO)CCCNC(=N)N)CCCCNNANANANANANAin situ brain perfusionNANA NA Permeability NA NA NA Unidirectional flux rate constant 0.0042 mL/(g x min) Direct iodination 10822104
b3pdb_1089Ziconotide, SNX-111,CKGKGAKCSRLMYDCCTGSCRSGKCCys-Lys-Gly-Lys-Gly-Ala-Lys-Cys-Ser-Arg-Leu-Met-Tyr-Asp-Cys-Cys-Thr-Gly-Ser-Cys-Arg-Ser-Gly-Lys-CysNANACys1-Cys16; Cys8-Cys20; Cys15-Cys2525LinearNAChemically synthesizedC[C@H]1C(=O)N[C@H](C(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N1)CCCCN)CCCCN)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N3)CO)[C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)CO)CCCNC(=N)N)CC(C)C)CCSC)CC4=CC=C(C=C4)O)CC(=O)O)C(=O)N)CCCCN)CO)CCCNC(=N)N)CCCCNNANANANANANAin situ brain perfusionNANA NA Permeability NA NA NA Initial distribution vaolume 0.0018 ml/g Direct iodination 10822104
b3pdb_1090Ziconotide, SNX-111,CKGKGAKCSRLMYDCCTGSCRSGKCCys-Lys-Gly-Lys-Gly-Ala-Lys-Cys-Ser-Arg-Leu-Met-Tyr-Asp-Cys-Cys-Thr-Gly-Ser-Cys-Arg-Ser-Gly-Lys-CysNANACys1-Cys16; Cys8-Cys20; Cys15-Cys2525LinearNAChemically synthesizedC[C@H]1C(=O)N[C@H](C(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N1)CCCCN)CCCCN)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N3)CO)[C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)CO)CCCNC(=N)N)CC(C)C)CCSC)CC4=CC=C(C=C4)O)CC(=O)O)C(=O)N)CCCCN)CO)CCCNC(=N)N)CCCCNNANACapillary depletionNANANANANANA NA NA NA NA NA Rpellet 1.31% Direct iodination 10822104
b3pdb_1091Ziconotide, SNX-111,CKGKGAKCSRLMYDCCTGSCRSGKCCys-Lys-Gly-Lys-Gly-Ala-Lys-Cys-Ser-Arg-Leu-Met-Tyr-Asp-Cys-Cys-Thr-Gly-Ser-Cys-Arg-Ser-Gly-Lys-CysNANACys1-Cys16; Cys8-Cys20; Cys15-Cys2525LinearNAChemically synthesizedC[C@H]1C(=O)N[C@H](C(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N1)CCCCN)CCCCN)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N3)CO)[C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)CO)CCCNC(=N)N)CC(C)C)CCSC)CC4=CC=C(C=C4)O)CC(=O)O)C(=O)N)CCCCN)CO)CCCNC(=N)N)CCCCNNANACapillary depletionNANANANANANA NA NA NA NA NA Rsupernatant 5.58% Direct iodination 10822104
b3pdb_1092SNX-194CKGKGAKCSRL-Nle-YDCCTGSCRSGKCCys-Lys-Gly-Lys-Gly-Ala-Lys-Cys-Ser-Arg-Leu-Nle-Tyr-Asp-Cys-Cys-Thr-Gly-Ser-Cys-Arg-Ser-Gly-Lys-CysNANACys1-Cys16; Cys8-Cys20; Cys15-Cys2525LinearNAChemically synthesizedNANANABMECNANANANANANA NA Permeability NA NA NA Permeability coefficient 0.00001083 cm/s NA 10822104
b3pdb_1121Neuromedin UYKVNEYQGPVAPSGGFFLFRPRNTyr-Lys-Val-Asn-Glu-Tyr-Gln-Gly-Pro-Val-Ala-Pro-Ser-Gly-Gly-Phe-Phe-Leu-Phe-Arg-Pro-Arg-AsnNANANA25LinearNAbacterialNANANAEfflux study ICUNANANANANANA NA Permeability NA NA NA Brain elemination rate constant 0.0112 min-1 Direct iodination 27040796
b3pdb_1122Neuromedin UYKVNEYQGPVAPSGGFFLFRPRNTyr-Lys-Val-Asn-Glu-Tyr-Gln-Gly-Pro-Val-Ala-Pro-Ser-Gly-Gly-Phe-Phe-Leu-Phe-Arg-Pro-Arg-AsnNANANA25LinearNAbacterialNANANACapillary depletionNANANANANANA NA NA NA NA NA % parenchyma 83% Direct iodination 27040796
b3pdb_1123Neuromedin UYKVNEYQGPVAPSGGFFLFRPRNTyr-Lys-Val-Asn-Glu-Tyr-Gln-Gly-Pro-Val-Ala-Pro-Ser-Gly-Gly-Phe-Phe-Leu-Phe-Arg-Pro-Arg-AsnNANANA25LinearNAbacterialNANANACapillary depletionNANANANANANA NA NA NA NA NA % capillary 17% Direct iodination 27040796
b3pdb_1124Neuromedin UYKVNEYQGPVAPSGGFFLFRPRNTyr-Lys-Val-Asn-Glu-Tyr-Gln-Gly-Pro-Val-Ala-Pro-Ser-Gly-Gly-Phe-Phe-Leu-Phe-Arg-Pro-Arg-AsnNANANA25LinearNAbacterialNANANANANANANAIntravenous NANA NA Permeability NA NA NA Unidirectional influx rate constant 0.00131 mL/(g x min) Direct iodination 27040796
b3pdb_1160PepH4KSKAINVLRGFRKEIGRMLNILNLysSerLysAlaIleAsnValLeuArgGlyPheArgLysGluIleGlyArgMetLeuAsnIleLeuAsnNANANA23LinearNAviralNANANAInitial concentration in donor chamber-CultureNANANANANANA NA Permeability NA NA NA Translocated 63.45% 63.45% 28263555
b3pdb_1178D3D3RPRTRLHTHRNRRPRTRLHTHRNRArg-Pro-Arg-Thr-Arg-Leu-His-Thr-His-Arg-Asn-Arg-Arg-Pro-Arg-Thr-Arg-Leu-His-Thr-His-Arg-Asn-ArgNANANA24LinearNAHemoglobinNANANANANANANAIntravenous NANA NA Permeability NA NA NA Brain to plasma ratio 0.6 H3/C14 27086111
b3pdb_1179RD2D3PTLHTHNRRRRRRPRTRLHTHRNRPro-Thr-Leu-His-Thr-His-Asn-Arg-Arg-Arg-Arg-Arg-Arg-Pro-Arg-Thr-Arg-Leu-His-Thr-His-Arg-Asn-ArgNANANA24LinearNAChemically synthesizedNANANANANANANAIntravenous NANA NA Permeability NA NA NA Brain to plasma ratio 0.6 H3/C14 27086111
b3pdb_1180RD2D3PTLHTHNRRRRRRPRTRLHTHRNRPro-Thr-Leu-His-Thr-His-Asn-Arg-Arg-Arg-Arg-Arg-Arg-Pro-Arg-Thr-Arg-Leu-His-Thr-His-Arg-Asn-ArgNANANA24LinearNAChemically synthesizedNANANANANANANAIntravenous NANA NA Permeability NA NA NA Peak response 0.3 µL/(g x min) H3/C14 27086111
b3pdb_1181RD2D3PTLHTHNRRRRRRPRTRLHTHRNRPro-Thr-Leu-His-Thr-His-Asn-Arg-Arg-Arg-Arg-Arg-Arg-Pro-Arg-Thr-Arg-Leu-His-Thr-His-Arg-Asn-ArgNANANA24LinearNAChemically synthesizedNANANANANANANAIntravenous NANA NA Permeability NA NA NA Unidirectional influx rate constant 0.0003 ml/(g x min) H3/C14 27086111
b3pdb_1182RD2D3PTLHTHNRRRRRRPRTRLHTHRNRPro-Thr-Leu-His-Thr-His-Asn-Arg-Arg-Arg-Arg-Arg-Arg-Pro-Arg-Thr-Arg-Leu-His-Thr-His-Arg-Asn-ArgNANANA24LinearNAChemically synthesizedNANANANANANANAIntravenous NANA NA Permeability NA NA NA Initial disrobution volume 0.0512 ml/g H3/C14 27086111
b3pdb_1183cRD2D3PTLHTHNRRRRRRPRTRLHTHRNRPro-Thr-Leu-His-Thr-His-Asn-Arg-Arg-Arg-Arg-Arg-Arg-Pro-Arg-Thr-Arg-Leu-His-Thr-His-Arg-Asn-ArgNANANA24LinearNAChemically synthesizedNANANANANANANAIntravenous NANA NA Permeability NA NA NA Peak response 2 µL/(g x min) H3/C14 29225107
b3pdb_1184cRD2D3PTLHTHNRRRRRRPRTRLHTHRNRPro-Thr-Leu-His-Thr-His-Asn-Arg-Arg-Arg-Arg-Arg-Arg-Pro-Arg-Thr-Arg-Leu-His-Thr-His-Arg-Asn-ArgNANANA24LinearNAChemically synthesizedNANANANANANANAIntravenous NANA NA Permeability NA NA NA Unidirectional influx rate constant 0.002 ml/(g x min) H3/C14 29225107
b3pdb_1185cRD2D3PTLHTHNRRRRRRPRTRLHTHRNRPro-Thr-Leu-His-Thr-His-Asn-Arg-Arg-Arg-Arg-Arg-Arg-Pro-Arg-Thr-Arg-Leu-His-Thr-His-Arg-Asn-ArgNANANA24LinearNAChemically synthesizedNANANANANANANAIntravenous NANA NA Permeability NA NA NA Initial disrobution volume 0.1955 ml/g H3/C14 29225107
b3pdb_1200tANK6RKRIRLVTKKKRRKRIRLVTKKKRArg-Lys-Arg-Ile-Arg-Leu-Val-Thr-Lys-Lys-Lys-Arg-Arg-Lys-Ile-Arg-Leu-Val-Thr-Lys-Lys-Lys-ArgNANANA24LinearNAmouseNANANANANANANAIntravenous NANA NA Permeability NA NA NA Peak response 1.6 µL/(g x min) H3/C14 29966196
b3pdb_1201tANK6RKRIRLVTKKKRRKRIRLVTKKKRArg-Lys-Arg-Ile-Arg-Leu-Val-Thr-Lys-Lys-Lys-Arg-Arg-Lys-Ile-Arg-Leu-Val-Thr-Lys-Lys-Lys-ArgNANANA24LinearNAmouseNANANANANANANAIntravenous NANA NA Permeability NA NA NA Unidirectional influx rate constant 0.0016 mL/(g x min) H3/C14 29966196
b3pdb_1202tANK6RKRIRLVTKKKRRKRIRLVTKKKRArg-Lys-Arg-Ile-Arg-Leu-Val-Thr-Lys-Lys-Lys-Arg-Arg-Lys-Ile-Arg-Leu-Val-Thr-Lys-Lys-Lys-ArgNANANA24LinearNAmouseNANANANANANANAIntravenous NANA NA Permeability NA NA NA Unidirectional influx rate constant 0.5833 ml/g H3/C14 29966196
b3pdb_1218dNP2KIKKVKKKGRKGSKIKKVKKKGRKNANANANA24NACationicChemically synthesizedNAJurkat cells2 μMConfocal microscopydNP2 enables the delivery of LRR domain of NLRX1 into T cellsC57BL/6J MiceNAIntraperitonealConfocal microscopydNP2 enables the delivery of LRR domain of NLRX1 into T cells It directly inhibits the functions of effector T cells and ameliorates disease severity of EAE with NA NA Combined with LRR Encephalomyelitis NA NA NA 32194859